Skip to content

CorMedix CRMD Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$181.01M$163.06M
$11.06M+3,659%$677K+340%$464.69K+411%$328.24K+294%$294.17K+289%
$14.91M+108%$13.83M+126%$11.44M+85.9%$8.6M+45.0%$7.18M+25.6%
$197.69M+1,557%$175.05M+446%$74.97M+234%$30.46M+160%-$13.57M+70.1%
$2.98M+4,505%$2.26M+1,848%$550.04K+36.9%$54.03K-86.6%$64.69K-82.7%
-$308.57M-2,589%-$311.73M-1,548%-$311.73M-1,548%-$14.09M-196%$12.39M+108%
$221.68M+582%$239.87M+811%$251.15M+1,520%$114.69M+159%$32.51M-33.1%
$194.71M+1,528%$172.79M+441%$74.42M+233%$30.41M+159%-$13.63M+70.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does CorMedix generate?
CorMedix (CRMD) generated $197.7M in operating cash flow over the trailing twelve months.
What is CorMedix's free cash flow?
After $3.0M of capital expenditures, CorMedix's free cash flow was $194.7M over the trailing twelve months, up 1528.3% year over year.
Where does CorMedix's cash flow data come from?
Every line is extracted from CorMedix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.